European Distribution Data

In collaboration with industry regulators and stakeholders, PPTA has developed a system that we believe is the best way to present the distribution of core plasma protein therapies in Europe. The European Distribution Data Program is a voluntary manufacturer initiative undertaken in response to drug shortage concerns, and is intended to provide a reliable, country-by-country assessment of the availability of these life-saving therapies.

PPTA’s web-based system provides aggregate, monthly distribution data for the following categories of plasma protein therapies:

• Albumin ≤ 5%
• Albumin 20% - 25%
• Intravenous Immune Globulin (IVIG)
• Subcutaneous and Intra-Muscular Immune Globulin (SC/IM IG)
• Plasma-Derived Factor VIII
• Plasma-Derived Factor IX 
  
  

* For some countries there is no reportable data available per SOPs.